Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fomsgaard

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
APMIS. Supplementum|January 1, 1990
Antibodies to lipopolysaccharides: some diagnostic and protective aspectsA Fomsgaard
Immunology Letters|March 5, 1999
HIV-1 DNA vaccinesA Fomsgaard
Ugeskrift for Laeger|April 5, 1993
[Septomonab (Centoxin) in the treatment of gram-negative septicemia]A Fomsgaard
Ugeskrift for Laeger|August 2, 2000
[Do we owe something?]A Fomsgaard
Ugeskrift for Laeger|September 4, 1995
[Genetic immunization--"the biological equivalent of cold fusion"?]A Fomsgaard
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 1, 1989
Protective properties of a human IgG preparation rich in antibodies to a wide spectrum of lipopolysaccharidesA Fomsgaard, C Galanos
Ugeskrift for Laeger|August 6, 1999
[Hepatitis G virus or hepatitis GB virus C]A Heinsen, A Fomsgaard
Journal of Immunoassay|January 1, 1987
ELISA for human IgG and IgM anti-lipopolysaccharide antibodies with indirect standardizationA Fomsgaard, B Dinesen
Ugeskrift for Laeger|August 17, 1987
[Treatment of patients with septic shock by endotoxin antibodies]A Fomsgaard, L Baek
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|March 1, 1993
Effect of a human IgG preparation rich in antibodies to a wide range of lipopolysaccharides on gram-negative bacterial sepsis in burned miceA Fomsgaard, I A Holder
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
APMIS. Supplementum|January 1, 1990
Antibodies to lipopolysaccharides: some diagnostic and protective aspectsA Fomsgaard
Immunology Letters|March 5, 1999
HIV-1 DNA vaccinesA Fomsgaard
Ugeskrift for Laeger|April 5, 1993
[Septomonab (Centoxin) in the treatment of gram-negative septicemia]A Fomsgaard
Ugeskrift for Laeger|August 2, 2000
[Do we owe something?]A Fomsgaard
Ugeskrift for Laeger|September 4, 1995
[Genetic immunization--"the biological equivalent of cold fusion"?]A Fomsgaard
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 1, 1989
Protective properties of a human IgG preparation rich in antibodies to a wide spectrum of lipopolysaccharidesA Fomsgaard, C Galanos
Ugeskrift for Laeger|August 6, 1999
[Hepatitis G virus or hepatitis GB virus C]A Heinsen, A Fomsgaard
Journal of Immunoassay|January 1, 1987
ELISA for human IgG and IgM anti-lipopolysaccharide antibodies with indirect standardizationA Fomsgaard, B Dinesen
Ugeskrift for Laeger|August 17, 1987
[Treatment of patients with septic shock by endotoxin antibodies]A Fomsgaard, L Baek
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|March 1, 1993
Effect of a human IgG preparation rich in antibodies to a wide range of lipopolysaccharides on gram-negative bacterial sepsis in burned miceA Fomsgaard, I A Holder
Pageof 9